Patients with type 1 and type 2 diabetes have a high risk of cardiovascular disease (CVD), but now, a new study shows that type 1 diabetes patients are more susceptible to both cardiovascular and renal disease.
Although different insulin analogs, pumps, and sensors have been proven to work, studies have shown that few children and adolescents achieve recommended HbA1c targets.
Physicians and parents have ranked important features of conducting type 1 diabetes screening tests, which is crucial due to the increasing prevalence of type 1 diabetes in children.
Children who received a new diagnosis of type 1 diabetes during the COVID-19 pandemic are presenting with higher rates of diabetic ketoacidosis than in the previous 2 years.
Researchers implemented an electronic medical record-based depressive symptom screen in type 1 diabetes mellitus adolescents seen in an outpatient clinic.
Researchers analyzed diabetes mobile applications to evaluate patient self-management capabilities and the compliance of these apps with diabetes care guidelines.
The CMS interim regulations are aimed at improving access to telemedicine and remote monitoring services in an effort to circumvent unnecessary exposure to COVID-19.
In the COVID-19 pandemic, there are specific considerations that should be made for patients with diabetes, who are at greater risk for severe infection.
The approval was based on data from an active-controlled, treat-to-target trial (Onset7) that included 777 pediatric patients (aged 2 to 17 years) with type 1 diabetes.
